Association of single-point insulin sensitivity estimator with renal pathology in type 2 diabetes

Background Distinguishing diabetic nephropathy (DN) from non-diabetic renal disease (NDRD) in patients with type 2 diabetes remains challenging without kidney biopsy. Whether the single-point insulin sensitivity estimator (SPISE) is associated with biopsy-defined renal pathology is unknown. Methods This retrospective, single-center study included consecutive adults with type 2 diabetes who underwent kidney biopsy between November 2011 and April 2026 and were diagnosed with pure DN or isolated NDRD. SPISE was calculated from BMI, fasting triglycerides, and HDL-C and analyzed as both a continuous and categorical variable. SPISE associations with renal pathology were examined using Firth penalized logistic regression and restricted cubic spline analyses, with additional subgroup and interaction analyses. Exploratory comparisons of clinical models with and without SPISE assessed discrimination, calibration, and reclassification. Results A total of 187 patients were included, with 67 (35.8%) classified as pure DN and 120 (64.2%) as isolated NDRD. Higher SPISE was associated with greater odds of pure DN after clinical adjustment (OR per 1-SD increase, 1.84; 95% CI, 1.23–2.77; P = 0.003), with consistent findings in categorical analyses. Spline analysis showed a positive association without evidence of non-linearity. Incorporating SPISE into a model based on conventional clinical indicators increased the AUC from 0.886 to 0.901, although the difference was not statistically significant (DeLong P = 0.138). Category-free NRI (0.551; P < 0.001) and IDI (0.043; P = 0.006) favored the model with SPISE, while the calibration curves were similar with and without SPISE. Conclusion Higher SPISE was associated with greater odds of pure DN than isolated NDRD. Whether SPISE adds clinically useful information to prebiopsy assessment requires prospective multicenter validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2026-11-19
DOI
https://doi.org/10.3389/fnut.2026.2004594
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of single-point insulin sensitivity estimator with renal pathology in type 2 diabetes

Tingting Su, Lu-Huai Feng, Yang Lu, Rongmei Nong
Frontiers in Nutrition
Chronic Kidney Disease and Diabetes
article

Association of single-point insulin sensitivity estimator with renal pathology in type 2 diabetes

Tingting Su, Lu-Huai Feng, Yang Lu, Rongmei Nong
article en

Abstract

Background Distinguishing diabetic nephropathy (DN) from non-diabetic renal disease (NDRD) in patients with type 2 diabetes remains challenging without kidney biopsy. Whether the single-point insulin sensitivity estimator (SPISE) is associated with biopsy-defined renal pathology is unknown. Methods This retrospective, single-center study included consecutive adults with type 2 diabetes who underwent kidney biopsy between November 2011 and April 2026 and were diagnosed with pure DN or isolated NDRD. SPISE was calculated from BMI, fasting triglycerides, and HDL-C and analyzed as both a continuous and categorical variable. SPISE associations with renal pathology were examined using Firth penalized logistic regression and restricted cubic spline analyses, with additional subgroup and interaction analyses. Exploratory comparisons of clinical models with and without SPISE assessed discrimination, calibration, and reclassification. Results A total of 187 patients were included, with 67 (35.8%) classified as pure DN and 120 (64.2%) as isolated NDRD. Higher SPISE was associated with greater odds of pure DN after clinical adjustment (OR per 1-SD increase, 1.84; 95% CI, 1.23–2.77; P = 0.003), with consistent findings in categorical analyses. Spline analysis showed a positive association without evidence of non-linearity. Incorporating SPISE into a model based on conventional clinical indicators increased the AUC from 0.886 to 0.901, although the difference was not statistically significant (DeLong P = 0.138). Category-free NRI (0.551; P < 0.001) and IDI (0.043; P = 0.006) favored the model with SPISE, while the calibration curves were similar with and without SPISE. Conclusion Higher SPISE was associated with greater odds of pure DN than isolated NDRD. Whether SPISE adds clinically useful information to prebiopsy assessment requires prospective multicenter validation.

Frontiers in NutritionVol. 13
Guangxi Medical University (CN), The People's Hospital of Guangxi Zhuang Autonomous Region (CN), Tumor Hospital of Guangxi Medical University (CN)
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon